Kotak Healthcare Fund Direct Growth
NAV as on 29-04-2025
₹ 13.29
▲1.9%
1D
Inception Returns
23.4%
/yr
Historical NAV & Returns
Absolute
▲
▼
716 people have invested ₹ 12.1L in Kotak Healthcare Fund Direct Growth in the last three months
About Kotak Healthcare Fund Direct Growth
Kotak Healthcare Fund Direct Growth is an equity fund. This fund was started on 11 December, 2023. The fund is managed by Shibani Kurian, Abhishek Bisen. The fund could potentially beat inflation in the long-run.
Key Parameters
- Kotak Healthcare Fund Direct Growth has ₹412 Cr worth of assets under management (AUM) as on Mar 2025 and is less than category average.
- The fund has an expense ratio 0.8.
Returns
Kotak Healthcare Fund Direct Growth has given a CAGR return of 23.41% since inception. Over the last 1 year the fund has given a CAGR return of 17.28%.
Holdings
Kotak Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Max Healthcare Institute Ltd Ordinary Shares, Cipla Ltd, Divi's Laboratories Ltd, Torrent Pharmaceuticals Ltd
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
Investment objective of Kotak Healthcare Fund Direct Growth
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 100.00 and for SIP is INR 100.00. Kotak Healthcare Fund Direct Growth has no lock in period.
Kotak Healthcare Fund Direct Growth Overview
| Expense ratio | 0.79% |
Benchmark | Nifty Healthcare Index PR INR |
| AUM | ₹412 Cr |
| Inception Date | 11 December, 2023 |
| Min Lumpsum/SIP | ₹100/₹100 |
Exit Load | 0.5% |
| Lock In | No Lock-in |
TurnOver | 4.89% |
| STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
Trailing Returns
as on (29-Apr-25)
Fund Distribution
as on (31-Mar-25)
Large cap
38.8%
Mid cap
30.2%
Small cap
27.1%
Sector Allocation
Health
97.3%
Basic Materials
2.7%
All changes are between Jan'25 and Mar'25
- This fund’s returns stands at 8.04% whereas the fund’s underlying benchmark Nifty 500 returns stands at 7.25% as on Mar'25
- This fund outperformed Nifty 500 by 0.79% in Mar'25
- AUM of the fund stands at 411.5 Cr as of Mar'25
- AUM increased by 31.7 Cr between Mar'25 and Feb'25
Top Stocks bought last month
Max Healthcare Institute Ltd Ordinary Shares's allocation increased from 6.05% to 8.13%
Laxmi Dental Ltd's allocation increased from 1.82% to 2.2%
Krishna Institute of Medical Sciences Ltd's allocation increased from 2.03% to 2.33%
Top Stocks sold last month
Cipla Ltd's allocation decreased from 6.37 % to 6.03 %
Divi's Laboratories Ltd's allocation decreased from 5.19 % to 5.05 %
J.B. Chemicals & Pharmaceuticals Ltd's allocation decreased from 4.11 % to 3.75 %
Large Cap allocation has gone down from 39.5% to 38.8%
Small Cap allocation has gone down from 27.8% to 27.1%
Mid Cap allocation has gone up from 29.6% to 30.2%
Cash allocation has gone up from 1.3% to 1.7%
Top 2 Sectors in March were Health, Basic Materials
Mar'25
Health
97%
Basic Materials
3%
Feb'25
Health
97%
Basic Materials
3%
Holdings | Weight% | 1M Change | |
|---|---|---|---|
 Sun Pharmaceuticals Industries Ltd | 17.91% | 0% | |
 Max Healthcare Institute Ltd Ordinary Shares | 8.13% | 29.8% | |
 Cipla Ltd | 6.03% | 0% | |
 Divi's Laboratories Ltd | 5.05% | 0% | |
 Torrent Pharmaceuticals Ltd | 3.84% | 0% |
See all
Funds | 1Y Returns | 3Y Returns | 5Y Returns | Since Inception |
|---|---|---|---|---|
Kotak Healthcare Fund Direct Growth | 17.28% | - | - | 23.41% |
 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth | 25.47% | 25.13% | 26.81% | 22.86% |
 SBI Healthcare Opportunities Fund Direct Growth | 25.35% | 24.98% | 26.68% | 18.44% |
 LIC MF Healthcare Fund Direct Growth | 22.27% | 17.85% | 19.59% | 20.34% |
See all
Top Growth Drivers | 1M Return |
|---|---|
 Sun Pharmaceutical Industries Ltd | 8.4% |
 Max Healthcare Institute Ltd | 1.5% |
Loading...
We are taking more time than usual
Shibani Kurian
Fund Manager of Kotak Healthcare Fund Direct Growth, since 11 December 2023
Top funds managed
Abhishek Bisen
Fund Manager of Kotak Healthcare Fund Direct Growth, since 11 December 2023
Top funds managed
Fund House
Kotak Mahindra Asset Management Co Ltd
Total Schemes
Total AUM
₹4.57L Cr
as on 31-Mar-2025
Address
Kotak Mahindra Asset management Company Limited,2nd Floor, 12-BKC, Plot No C-12,G Block, BKC, Bandra (East),Mumbai - 400 051
Phone
91-22-40930000
Website
fundaccops@kotakmutual.com
Kotak Healthcare Fund Direct Growth Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 23.41% since inception which is more than its category average return of 17.6%
Fund Allocations
This fund has an allocation of 98.27% in Equity, 0% in Debt and 1.73% in Cash related instruments
AUM size ₹412 Cr
This fund has AUM of ₹412 Cr which is less than its category average of ₹ 1821 Cr
Expense Ratio 0.79%
This fund has an expense ratio of 0.79% which is less than its category average expense ratio of 1.44%
More funds from Kotak
3Y CAGR
▲ 23.98
5Y CAGR
▲ 28.43
3Y CAGR
▲ 19.93
5Y CAGR
▲ 31.57
Frequently Asked Questions for Kotak Healthcare Fund Direct Growth
The current NAV of Kotak Healthcare Fund Direct Growth is ₹13.29 as on 29-Apr-2025.
Existing (Absolute + CAGR) as on 29-Apr-2025.
Kotak Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 2.57% | 2.57% |
6 Month Returns | -2.18% | -2.18% |
1 Year Returns | 17.28% | 17.28% |
3 Years Returns | 0% | 0% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
0.79% as on March 2025
₹412 Cr as on March 2025
Sun Pharmaceuticals Industries Ltd(17.91%), Max Healthcare Institute Ltd Ordinary Shares(8.13%), Cipla Ltd(6.03%), Divi's Laboratories Ltd(5.05%), Torrent Pharmaceuticals Ltd(3.84%) as on March 2025
The alpha ratio for the Kotak Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
Kotak Healthcare Fund Direct Growth | -3.51 | - | - |
As on March 2025
The alpha for Kotak Healthcare Fund Direct Growth is calculated against Nifty Healthcare Index PR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Kotak Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
Kotak Healthcare Fund Direct Growth | 1.04 | - | - |
As on March 2025
The Beta for Kotak Healthcare Fund Direct Growth is calculated with Nifty Healthcare Index PR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Kotak Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
Kotak Healthcare Fund Direct Growth | 0.42 | - | - |
As on March 2025
The sharpe ratio for Kotak Healthcare Fund Direct Growth is calculated with Nifty Healthcare Index PR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Kotak Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
Kotak Healthcare Fund Direct Growth | 21.01 | - | - |
As on March 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Shibani Kurian, Abhishek Bisen are the fund managers of Kotak Healthcare Fund Direct Growth
The Exit load of Kotak Healthcare Fund Direct Growth is 0.5%